Embolic Stroke of Undetermined Source and Patent Foramen Ovale Risk of Paradoxical Embolism Score Validation and Atrial Fibrillation Prediction

被引:28
|
作者
Strambo, Davide [1 ,2 ]
Sirimarco, Gaia [1 ,2 ]
Nannoni, Stefania [1 ,2 ]
Perlepe, Kalliopi [3 ]
Ntaios, George [3 ]
Vemmos, Kostantinos [4 ]
Michel, Patrik [1 ,2 ]
机构
[1] Lausanne Univ Hosp, Dept Clin Neurosci, Serv Neurol, Rue Bugnon 46, CH-1011 Lausanne, Switzerland
[2] Univ Lausanne, Lausanne, Switzerland
[3] Univ Thessaly, Sch Hlth Sci, Dept Internal Med, Fac Med, Larisa, Greece
[4] Alexandra Hosp, Med Sch Athens, Dept Clin Therapeut, Athens, Greece
关键词
atrial fibrillation; Bayes theorem; embolic stroke; foramen ovale; patent; prevalence; CRYPTOGENIC STROKE; MEDICAL THERAPY; ISCHEMIC-STROKE; CLOSURE; REGISTRY;
D O I
10.1161/STROKEAHA.120.032453
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose: The Risk of Paradoxical Embolism (RoPE) score stratifies patients with stroke according to the probability of having a patent foramen ovale (PFO), which (through Bayes theorem and simple assumptions) can be used to estimate the probability that a PFO is pathogenic in a given subgroup of patients with specific features (ie, a given RoPE score value): a higher PFO prevalence corresponds to a higher probability that a PFO is pathogenic. Among alternative mechanisms in embolic stroke of undetermined source (ESUS), the actual stroke cause may be covert atrial fibrillation. We aimed to validate the RoPE score in a large ESUS population and investigate the rate of stroke recurrence and new incident atrial fibrillation during follow-up according to PFO status and RoPE score. Methods: We pooled data of consecutive patients with ESUS from 3 prospective stroke registries. We assessed RoPE score's calibration and discrimination for the presence of PFO (and consequently for the probability that it is pathogenic). Multivariate logistic regression analysis was performed to identify factors associated with PFO. Results: Among 455 patients with ESUS (median age 59 years), 184 (40%) had PFO. The RoPE score's area under the receiver operating characteristic curve was 0.75. In addition to RoPE score variables, absence of left ventricular hypertrophy, absence of atherosclerosis, and infratentorial lesions were independently associated with PFO. In patients with PFO and RoPE 7 to 10, PFO and RoPE 0 to 6, and without PFO, new incident atrial fibrillation rate was 3.1%, 20.5%, and 31.8%, respectively (log-rank test=6.28, P=0.04). Stroke recurrences in patients with likely pathogenic PFO were not statistically different from other patients. Conclusions: This multicenter study validates the RoPE score to predict the presence/absence of PFO in patients with ESUS, which strongly suggests that RoPE score is helpful in identifying patients with ESUS with pathogenic versus incidental PFOs. Left ventricular hypertrophy, atherosclerosis, and infratentorial stroke may further improve the score. Low RoPE scores were associated with more incidental atrial fibrillation during 10-year follow-up.
引用
收藏
页码:1643 / 1652
页数:10
相关论文
共 50 条
  • [31] Embolic stroke of undetermined source: Beyond atrial fibrillation
    Arauz, A.
    Arteaga, C.
    Zapata-Gomez, C.
    Ramos-Ventura, C.
    Mendez, B.
    Otiniano-Sifuentes, R.
    Haseeb, S.
    Gonzalez-Oscoy, R.
    Baranchuk, A.
    NEUROLOGIA, 2022, 37 (05): : 362 - 370
  • [32] Embolic stroke of undetermined source correlates to atrial fibrosis without atrial fibrillation
    Tandon, Karman
    Tirschwell, David
    Longstreth, W. T., Jr.
    Smith, Bryn
    Akoum, Nazem
    NEUROLOGY, 2019, 93 (04) : E381 - E387
  • [33] Carotid plaques and detection of atrial fibrillation in embolic stroke of undetermined source
    Ntaios, George
    Perlepe, Kalliopi
    Sirimarco, Gaia
    Strambo, Davide
    Eskandari, Ashraf
    Karagkiozi, Efstathia
    Vemmou, Anastasia
    Koroboki, Eleni
    Manios, Efstathios
    Makaritsis, Konstantinos
    Michel, Patrik
    Vemmos, Konstantinos
    NEUROLOGY, 2019, 92 (23) : E2644 - E2652
  • [34] Embolic lesion pattern in stroke patients with patent Foramen ovale compared with patients lacking an embolic source
    Jauss, Marek
    Wessels, Tiemo
    Trittmacher, Susan
    Allendoerfer, Jens
    Kaps, Manfred
    STROKE, 2006, 37 (08) : 2159 - 2161
  • [35] Global Survey of the Frequency of Atrial Fibrillation-Associated Stroke: Embolic Stroke of Undetermined Source Global Registry
    Perera, Kanjana S.
    Vanassche, Thomas
    Bosch, Jackie
    Swaminathan, Balakumar
    Mundl, Hardi
    Giruparajah, Mohana
    Barboza, Miguel A.
    O'Donnell, Martin J.
    Gomez-Schneider, Maia
    Hankey, Graeme J.
    Yoon, Byung-Woo
    Roxas, Artemio, Jr.
    Lavallee, Philippa
    Sargento-Freitas, Joao
    Shamalov, Nikolay
    Brouns, Raf
    Gagliardi, Rubens J.
    Kasner, Scott E.
    Pieroni, Alessio
    Vermehren, Philipp
    Kitagawa, Kazuo
    Wang, Yongjun
    Muir, Keith
    Coutinho, Jonathan M.
    Connolly, Stuart J.
    Hart, Robert G.
    STROKE, 2016, 47 (09) : 2197 - 2202
  • [36] Left atrial diameter thresholds and new incident atrial fibrillation in embolic stroke of undetermined source
    Perlepe, Kalliopi
    Sirimarco, Gaia
    Strambo, Davide
    Eskandari, Ashraf
    Karagkiozi, Efstathia
    Vemmou, Anastasia
    Koroboki, Eleni
    Manios, Efstathios
    Makaritsis, Konstantinos
    Vemmos, Konstantinos
    Michel, Patrik
    Ntaios, George
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 75 : 30 - 34
  • [37] The Association of Patent Foramen Ovale Morphology and Stroke Size in Patients With Paradoxical Embolism
    Akhondi, Andre
    Gevorgyan, Rubine
    Tseng, Chi-Hong
    Slavin, Leo
    Dao, Catherine
    Liebeskind, David S.
    Tobis, Jonathan M.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (05) : 506 - U169
  • [38] Incidence of Atrial Fibrillation in Large Vessel Occlusion and Large Embolic Stroke of Undetermined Source
    Seachrist, Eric J.
    Petrone, Ashley
    Nevin, Connor
    Ranasinghe, Tamra
    Jacob, Sneha
    Ferari, Christopher
    Adcock, Amelia
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [39] Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale Results From RE-SPECT ESUS
    Diener, Hans-Christoph
    Chutinet, Aurauma
    Easton, J. Donald
    Granger, Christopher B.
    Kleine, Eva
    Marquardt, Lars
    Meyerhoff, Juliane
    Zini, Andrea
    Sacco, Ralph L.
    STROKE, 2021, 52 (03) : 1065 - 1068
  • [40] High Incidence of Atrial Fibrillation After Embolic Stroke of Undetermined Source in Posterior Cerebral Artery Territory
    Makimoto, Hisaki
    Kurt, Muhammed
    Gliem, Michael
    Lee, John-Ih
    Schmidt, Jan
    Mueller, Patrick
    Clasen, Lukas
    Brinkmeyer, Christoph
    Shin, Dong-In
    Jander, Sebastian
    Kelm, Malte
    Fuernkranz, Alexander
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (12):